YN372381 Celgosivir hydrochloride 141117-12-6

Celgosivir hydrochloride (MBI 3253 hydrochloride; MDL 28574 hydrochloride; MX3253 hydrochloride) is anα-glucosidase Iinhibitor; inhibits bovine viral diarrhoea virus (BVDV) with an IC50 of 1.27μM inin vitroassay.

YN251833 HIV-1 Rev 34-50 141237-50-5

HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity.

YN251802 CEF1, Influenza Matrix P... 141368-69-6

CEF1, Influenza Matrix Protein M1 (58-66) is an epitope derived from the matrix protein of the influenza A virus.

YN250334 Trifloxystrobin 141517-21-7

Trifloxystrobin (CGA 279202) is afungicide, with EC50s of 23.0 μg/L and 1.7 μg/L forDaphnia magnaneonate and embryos, respectively, after treatment for 48 h.

YN250006 Faropenem daloxate 141702-36-5

Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics. Faropenem daloxate is useful for penem and antibiotics. Faropenem medoxomil has excellent in vitro activity against Streptococcus pneumoniae, Haem...

YN250395 Fozivudine tidoxil 141790-23-0

Fozivudine tidoxil (BM-211290) is an orally active thioether lipid-zidovudine (ZDV) conjugate withanti-HIVactivity. Fozivudine tidoxil, a member of the NRTI family of drug, is incorporated into the newly synthesized str and o...

YN250909 (-)-Ketoconazole 142128-57-2

(-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

YN372728 (+)-Ketoconazole 142128-59-4

(+)-Ketoconazole ((+)-R 41400) is an imidazole anti-fungal agent, a CYP3A4 inhibitor. (+)-Ketoconazole, an imidazole anti-fungal agent, has often produced features of and rogen deficiency including decreased libido, gynecomastia, im...

YN250516 Entecavir 142217-69-4

Entecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).

YN250970 Adefovir dipivoxil 142340-99-6

Adefovir Dipivoxil is a reverse transcriptase inhibitor, used in the treatment of chronic hepatitis B virus (HBV).

YN251735 Glyasperin D 142561-10-2

Glyasperin D is a flavonoid isolated fromGlycyrrhiza uralensis, and possesses weaker anti-Helicobacter pyloriactivity.

YN250303 Azt-pmap 142629-81-0

Azt-pmap, a nucleoside analogue, is an aryl phosphate derivative of AZT. Azt-pmap shows anti-HIV activity. AZT is a nucleoside reverse transcriptase inhibitor (NRTI) for HIV infection.

YN483027 Neotuberostemonine 143120-46-1

Neotuberostemonine, one of the main antitussive alkaloids in the root of Stemona tuberosa Lour, attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages.

YN373434 NIM811 143205-42-9

NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailablemitochondrial permeability transition and cyclophilindual inhibitor, which exhibits potent in vitro activity against hepatitis C virus (HCV).

YN371029 Kresoxim-methyl 143390-89-0

Kresoxim-methyl (BAS 490 F), a Strobilurin-based fungicide, inhibits the respiration at thecomplex III (cytochrome bc1 complex). Kresoxim-methyl binds to complex III from yeast with an apparent Kdof 0.07μM proving a high aff...

YN322004 ALX 40-4C 143413-49-4

ALX 40-4C is a small peptide inhibitor of thechemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also a...

YN250721 Emtricitabine 143491-57-0

Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h.

YN250005 YYA-021 144217-65-2

YYA-021 is a small-molecule CD4 mimic that inhibits HIV entry, with high anti-HIV activity and low cytotoxicity.

YN250159 Gamithromycin 145435-72-9

Gamithromycin is a new macrolide antibiotic that is only registered for use in cattle to treat respiratory disorders such as bovine respiratory disease.

YN420289 Sophocarpine monohydrate 145572-44-7

Sophocarpine and matrine exert anti-cachectic effects probably through inhibition of TNF-alpha and IL-6 and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Sophocarpine injection (called the Kangke inj...